Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001193125-25-179038
Filing Date
2025-08-12
Accepted
2025-08-12 16:45:10
Documents
22

Document Format Files

Seq Description Document Type Size
1 S-3 d945821ds3.htm S-3 347250
2 EX-1.2 d945821dex12.htm EX-1.2 211650
3 EX-4.4 d945821dex44.htm EX-4.4 303759
4 EX-5.1 d945821dex51.htm EX-5.1 23029
5 EX-5.2 d945821dex52.htm EX-5.2 13011
6 EX-23.1 d945821dex231.htm EX-23.1 1653
7 EX-FILING FEES d945821dexfilingfees.htm   iXBRL EX-FILING FEES 38708
8 GRAPHIC g945821dsp6a.jpg GRAPHIC 3100
9 GRAPHIC g945821dsp6b.jpg GRAPHIC 2234
10 GRAPHIC g945821g0809124343462.jpg GRAPHIC 1790
11 GRAPHIC g945821g08k04.jpg GRAPHIC 36321
12 GRAPHIC g945821snap1.jpg GRAPHIC 3057
  Complete submission text file 0001193125-25-179038.txt   1174544

Data Files

Seq Description Document Type Size
24 EXTRACTED XBRL INSTANCE DOCUMENT d945821dexfilingfees_htm.xml XML 17694
Mailing Address 3115 MERRYFIELD ROW THIRD FLOOR SAN DIEGO CA 92121
Business Address 3115 MERRYFIELD ROW THIRD FLOOR SAN DIEGO CA 92121 (858) 465-6511
Erasca, Inc. (Filer) CIK: 0001761918 (see all company filings)

EIN.: 831217027 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-289537 | Film No.: 251207475
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)